Jane Street
JUNO

Jane Street’s Juno Therapeutics, Inc. JUNO Stock Holding History

Jane Street’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-25,300
Closed -$1.16M – 5819
2017
Q4 		$1.16M Sell
25,300
-66,600
-72% -$3.32M ﹤0.01% 2174
2017
Q3 		$4.12M Buy
91,900
+16,800
+22% +$573K 0.01% 1014
2017
Q2 		$2.25M Buy
75,100
+59,000
+366% +$1.46M 0.01% 1395
2017
Q1 		$357K Sell
16,100
-35,000
-68% -$751K ﹤0.01% 3240
2016
Q4 		$963K Buy
51,100
+34,900
+215% +$854K ﹤0.01% 2132
2016
Q3 		$486K Buy
16,200
+8,700
+116% +$271K ﹤0.01% 2802
2016
Q2 		$288K Sell
7,500
-16,900
-69% -$701K ﹤0.01% 3375
2016
Q1 		$929K Buy
24,400
+9,100
+59% +$317K 0.01% 1919
2015
Q4 		$673K Buy
+15,300
New +$759K ﹤0.01% 2153
2015
Q3 		– Sell
-97,000
Closed -$5.17M – 4459
2015
Q2 		$5.17M Buy
+97,000
New +$5.15M 0.03% 456

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Jane Street's JUNO Position: Q1 2018 in Review

Jane Street sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 16,643 shares — an estimated $761K sold.

Jane Street first reported a position in JUNO in Q4 2014 and held it in 11 quarters. The position peaked at $2.09M in Q1 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Jane Street reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Jane Street sold 16,643 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $761K.
  • Jane Street first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 11 quarters.
  • Jane Street's Juno Therapeutics, Inc. position peaked at $2.09M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Jane Street's 13F filing for Q1 2018, filed 15 May 2018.